BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33450878)

  • 21. Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.
    Chen CL; Chang DM; Chen TC; Lee CC; Hsieh HH; Huang FC; Huang KF; Guh JH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Feb; 60():29-41. PubMed ID: 23279865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells.
    Wang Y; Liu Q; Liu Z; Li B; Sun Z; Zhou H; Zhang X; Gong Y; Shao C
    Mutat Res; 2012 Jun; 734(1-2):20-9. PubMed ID: 22561209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells.
    Yan K; Zhang C; Feng J; Hou L; Yan L; Zhou Z; Liu Z; Liu C; Fan Y; Zheng B; Xu Z
    Eur J Pharmacol; 2011 Jul; 661(1-3):1-7. PubMed ID: 21545798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis.
    Naasani I; Seimiya H; Yamori T; Tsuruo T
    Cancer Res; 1999 Aug; 59(16):4004-11. PubMed ID: 10463599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways.
    Puthdee N; Seubwai W; Vaeteewoottacharn K; Boonmars T; Cha'on U; Phoomak C; Wongkham S
    Biol Pharm Bull; 2017; 40(6):751-757. PubMed ID: 28566619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
    Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
    Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells.
    Xiao N; Chen S; Ma Y; Qiu J; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
    Biochem Biophys Res Commun; 2012 Mar; 419(3):567-72. PubMed ID: 22369941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
    Li F; Dong X; Lin P; Jiang J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells.
    Khaw AK; Yong JW; Kalthur G; Hande MP
    Genes Chromosomes Cancer; 2012 Oct; 51(10):961-74. PubMed ID: 22736505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances in Nucleic Acid Binding Aspects of Berberine Analogs and Implications for Drug Design.
    Bhowmik D; Kumar GS
    Mini Rev Med Chem; 2016; 16(2):104-19. PubMed ID: 26349491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomerase inhibitors as anticancer therapy.
    Akiyama M; Hideshima T; Munshi NC; Anderson KC
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.
    Gan Y; Lu J; Yeung BZ; Cottage CT; Wientjes MG; Au JL
    AAPS J; 2015 Jan; 17(1):268-76. PubMed ID: 25425294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.
    Morais KDS; Arcanjo DDS; de Faria Lopes GP; da Silva GG; da Mota THA; Gabriel TR; Rabello Ramos DDA; Silva FP; de Oliveira DM
    Cell Biochem Funct; 2019 Jun; 37(4):273-280. PubMed ID: 31012504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.
    Chen X; Zha GF; Wang JQ; Liu XH
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decyl caffeic acid inhibits the proliferation of colorectal cancer cells in an autophagy-dependent manner in vitro and in vivo.
    Chen C; Kuo YH; Lin CC; Chao CY; Pai MH; Chiang EI; Tang FY
    PLoS One; 2020; 15(5):e0232832. PubMed ID: 32401800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer.
    Su YH; Tang WC; Cheng YW; Sia P; Huang CC; Lee YC; Jiang HY; Wu MH; Lai IL; Lee JW; Lee KH
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2261-72. PubMed ID: 25982393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
    Lu S; Obianom ON; Ai Y
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2869-2874. PubMed ID: 30037494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells.
    He W; Wang B; Zhuang Y; Shao D; Sun K; Chen J
    J Pharmacol Sci; 2012; 119(4):341-8. PubMed ID: 22850597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin induces G
    Chen MJ; Cheng AC; Lee MF; Hsu YC
    J Cell Physiol; 2018 Jun; 233(6):4618-4625. PubMed ID: 28833099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.